# A Study to Evaluate the Safety and Effectiveness of FK778 in Liver Transplant Patients

> **NCT00451932** · PHASE2 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 303 (actual)

## Conditions studied

- Liver Transplantation

## Interventions

- **DRUG:** FK778

## Key facts

- **NCT ID:** NCT00451932
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2005-09
- **Final completion:** 2005-09
- **Target enrollment:** 303 (ACTUAL)
- **Last updated:** 2008-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00451932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00451932, "A Study to Evaluate the Safety and Effectiveness of FK778 in Liver Transplant Patients". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT00451932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*